Zimmer Biomet’s revenue in the second quarter of 2025 increased with a 7% increase year over year, according to financial results posted Aug. 7.
Five things to know:
1. Quarterly sales reached $2.07 billion, and Zimmer Biomet’s net earnings were $152.8 million.
2. Knee sales increased 3.1% with $826 million, and hip sales were up 5.8% with $536.1 million.
3. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales rose 17.3% year over year to $550.6 million.
4. U.S. sales increased 6.1% year over year with $1.8 billion. International sales were just under $1 billion.
5. Zimmer Biomet projects its full-year revenue to increase 6.7% to 7.7% compared to 2024.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
